
India’s CDMO market is projected to double from US$ 7 billion to US$ 14 billion by 2028, driven by strong API and generic drug manufacturing capabilities, along with cost advantages over China. India’s Contract Development and Manufacturing Organization (CDMO) market is on track for substantial expansion, projected to double from...









